Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
Medication is billed separately
Why Does AgeRejuvenation's Medical Weight Loss Team Matter
Coaching and Behavioral Support: WeightWatchers includes behavioral support tools and coaching that are designed to help you build habits that last well beyond your time on medication
Does semaglutide slow digestion
Its primary functions include stimulating insulin release from the pancreas, suppressing glucagon (a hormone that raises blood sugar), slowing gastric emptying, and signalling satiety (fullness) to the brain